Literature DB >> 29473597

Erratum: Contraindications to intravenous rtPA for acute stroke: A critical reappraisal.

.   

Abstract

[This corrects the article on p. 177 in vol. 3.].

Entities:  

Year:  2013        PMID： 29473597      PMCID： PMC5765833          DOI： 10.1212/01.CPJ.0000435706.04846.53

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


  3 in total

1.  Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.

Authors:  Felipe de Los Ríos la Rosa; Jane Khoury; Brett M Kissela; Matthew L Flaherty; Kathleen Alwell; Charles J Moomaw; Pooja Khatri; Opeolu Adeoye; Daniel Woo; Simona Ferioli; Dawn O Kleindorfer
Journal:  Stroke       Date:  2012-03-22       Impact factor: 7.914

2.  Utilization of intravenous thrombolysis is increasing in the United States.

Authors:  Deena M Nasr; Waleed Brinjikji; Harry J Cloft; Alejandro A Rabinstein
Journal:  Int J Stroke       Date:  2012-08-09       Impact factor: 5.266

Review 3.  Temporal trends in acute stroke management.

Authors:  Dawn Kleindorfer; Felipe de los Rios La Rosa; Pooja Khatri; Brett Kissela; Jason Mackey; Opeolu Adeoye
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.